The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis
Status:
Terminated
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate if the combination of oral budesonide and rectal
hydrocortisone improves symptoms in patients with active ulcerative colitis. Also, we would
like to determine if oral budesonide and rectal hydrocortisone has fewer and less severe side
effects compared to standard steroids (prednisone).
Phase:
Phase 2
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore